Evidence map›Paper›PMID 41050119›Full record

ArticleKidney medicine2025

Severe Acute Kidney Injury Associated With Intestinal Ostomies.

Juan A Gómez-Fregoso, Jose J Zaragoza, Juan Alberto González-Duarte, Carlos M Nuño-Guzmán, Eduardo M Hernández-Barajas, Zarahi Andrade-Jorge, Juarez Correa-de Leon, Jorge L Padilla-Armas, Rebeca Lizzete Ornelas-Ruvalcaba, José Said Cabrera-Aguilar and 11 more

Abstract read
In one paragraph

Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Juan A Gómez-FregosoNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Jose J ZaragozaIntensive Care Unit, Hospital H+ Queretaro, Mexico.
Juan Alberto González-DuarteUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico.
Carlos M Nuño-GuzmánUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico.
Eduardo M Hernández-BarajasNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Zarahi Andrade-JorgeNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Juarez Correa-de LeonNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Jorge L Padilla-ArmasNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Rebeca Lizzete Ornelas-RuvalcabaNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
José Said Cabrera-AguilarNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Gael Chávez-AlonsoUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico.
Estefania Villalvazo-MacielUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico.
Carlos E Orozco-ChanUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico.
Gonzalo Rodríguez-GarcíaNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Guillermo Navarro-BlackallerNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Ramón Medina-GonzálezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Alejandro Martínez Gallardo-GonzálezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Luz Alcantar-VallinNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Gabriela J Abundis-MoraNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.
Guillermo García-GarcíaUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico.
Jonathan S Chávez-IñiguezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale & Objective: People with ostomies can experience high output, a risk of acute kidney injury (AKI). We evaluated patients with AKI associated with ostomies (ostomy-AKI) and compared with AKI of other etiologies (general-AKI) with the objective of describing their clinical presentation and their association with major adverse kidney events at 10 and 30-90 days (major adverse kidney events [MAKE] 10 and 30-90, respectively). Study Design: A retrospective cohort study. Setting & Participants: Conducted at the Hospital Civil of Guadalajara. We included patients with Ostomy-AKI and General-AKI. Exposures or Predictors: Ostomy-AKI. Outcomes: Describing and differentiating their clinical presentation and their association with MAKE 10 and MAKE 30-90, in addition to its individual components, as death, new requirement for dialysis, or ≥25% decline in the estimated glomerular filtration rate from baseline. Analytical Approach: Analyzed the risk by logistic regression model and a multivariate Cox proportional hazard. Results: From February 2020 to October 2023, 84 patients with ostomy-AKI and 348 with general-AKI were included. Most ostomy-AKI were male (78.7 vs 56.2%), the mean ostomy output was 980 mL/day (760-1,700), 82.9% requiring fluid adjustment. Ostomies had been created for cancer (46%) 2.3 months before AKI. The etiology of ostomy-AKI, compare to general-AKI, was more frequently due to hypovolemia (48.9% vs 24.5%) and was of greater AKI severity (stage 3, 82.9% vs 63.9%). Both groups had the same frequency of MAKE 10 (94%), and their individual components. MAKE 30-90 occurred more frequently in ostomy-AKI (65.9% vs 49.3%) as well as mortality (59.5% vs 37%), doubling this risk (OR 2.403; 95% CI, 1.090-5.299; Limitations: A retrospective cohort, residual confounding, and small sample size. Conclusions: In comparison with general-AKI, patients with ostomy-AKI present more often with hypovolemia and greater AKI stage, had a higher mortality at 30-90 day follow-up, and a 2.5-fold increase in risk of MAKE.

Indexed as

Acute kidney injuryhypovolemiakidney replacement therapymajor adverse kidney eventmortalityostomy

Identifiers

PMID41050119
PMCPMC12494838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.